Prosecution Insights
Last updated: April 19, 2026

Angeles Therapeutics, Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17264788 IMPROVING THE EFFICACY AND SAFETY OF ADOPTIVE CELLULAR THERAPIES WESTON, ALYSSA G 1633 Final Rejection Jan 29, 2021
15734203 DIVERSE ANTIGEN BINDING DOMAINS, NOVEL PLATFORMS AND OTHER ENHANCEMENTS FOR CELLULAR THERAPY ARON, KIMBERLY A 1633 Final Rejection Dec 01, 2020

Managing Angeles Therapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month